Insulin Glargine (U-100) Vials and Novo-Clavamoxin 250
Determining the interaction of Insulin Glargine (U-100) Vials and Novo-Clavamoxin 250 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: amoxicillin / clavulanate
Brand name: Augmentin, Augmentin ES-600, Augmentin XR
Synonyms: Amoxicillin and Clavulanate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Glargine (U-100) Vials-Novo-Furan Suspension
- Insulin Glargine (U-100) Vials-Novo-Hydrocort Cream Topical application
- Insulin Glargine (U-100) Vials-Novo-Hydrocort Topical application
- Insulin Glargine (U-100) Vials-Novo-Lexin
- Insulin Glargine (U-100) Vials-Novo-Methacin Suppositories
- Insulin Glargine (U-100) Vials-Novo-Peridol
- Novo-Clavamoxin 250-Insulin Glargine (U-300) Pens
- Novo-Clavamoxin 250-Insulin glargine and lixisenatide
- Novo-Clavamoxin 250-Insulin glargine and lixisenatide Subcutaneous
- Novo-Clavamoxin 250-Insulin glargine, recombinant Subcutaneous
- Novo-Clavamoxin 250-Insulin glulisine
- Novo-Clavamoxin 250-Insulin Glulisine (Cartridges and Pens)